Montclair, NJ, United States of America

Carolyn L Ruby


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carolyn L Ruby

Introduction

Carolyn L Ruby is a distinguished inventor based in Montclair, NJ (US). She has made significant contributions to the field of immunosuppressant agents, holding a total of 3 patents. Her work is particularly notable for its impact on organ transplantation.

Latest Patents

One of her latest patents is a process for producing the immunosuppressant agent L-682,993. This innovative process involves the use of a new mutant microorganism, Streptomyces sp. (Merck Culture Collection MA 7017) ATCC No. 55334, which is a blocked second-generation mutant of Streptomyces sp. (MA 6858) ATCC No. 55098. The macrolide immunosuppressant is crucial in preventing human host rejection of foreign organ transplants, such as bone marrow and heart transplants. Another significant patent is for the production of the immunosuppressant agent L-683,942 by fermentation. This process utilizes the mutant microorganism, Streptomyces hygroscopicus subsp. ascomyceticus (Merck Culture Collection MA 6646) ATCC No. 53855, which is a blocked mutant of Streptomyces hygroscopicus subsp. ascomyceticus (MA 6475) ATCC No. 14891. This macrolide immunosuppressant also plays a vital role in preventing organ transplant rejection.

Career Highlights

Carolyn L Ruby is currently employed at Merck & Company, Inc., where she continues to advance her research in immunosuppressants. Her work has been instrumental in developing new methods for producing these critical agents, which are essential for successful organ transplants.

Collaborations

Throughout her career, Carolyn has collaborated with notable colleagues, including Byron H Arison and Keith M Gewain. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Carolyn L Ruby's contributions to the field of immunosuppressants are invaluable, particularly in the context of organ transplantation. Her innovative processes and dedication to research continue to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…